LATEST TRIALS

  • Bladder Cancer
    A phase II single arm clinical trial of nivolumab (BMS936558) in subjects with metastatic or unresectable urothelial cancer who have progressed or recurred following treatment with a platinum agent
  • Multiple Diagnosis
    A first-in-human, multicenter, open-label, multiple ascending dose Phase I study in patients with advanced solid tumors to determine the safety, pharmacokinetics and pharmacodynamics of intratumorally administered ADC-1013
  • Prostate Cancer
    Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer (DUALIDES)

NORDIC COOPERATION

Norway Norway Sweden Finland Aarhus Herlev Copenhagen